We introduce ourselves
Mirum Pharmaceuticals, Inc. is a Foster City, California-based biopharmaceutical company dedicated to transforming the treatment of rare liver diseases. Mirum has one FDA-approved medication, LIVMARLI™ (maralixibat) oral solution, and a late-stage pipeline with two investigational therapies focused on advancing the treatment of cholestatic liver diseases affecting children and adults. Learn more about the company, its approved medication, and its ongoing clinical programs by visiting www.mirumpharma.com.
Read more
